Study To Assess Effectiveness and Adverse Events of Foscarbidopa/ Foslevodopa in Adult Participants With Advanced Parkinson Disease in Real Life Setting
NCT ID: NCT06639620
Last Updated: 2025-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2024-11-12
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Foslevodopa/foscarbidopa is an approved drug outside of US for the treatment of Parkinson's Disease. Approximately 200 adult participants who are prescribed foslevodopa/foscarbidopa by their doctors will be enrolled across approximately 30 sites in France.
Participants will receive foscarbidopa/ foslevodopa subcutaneous infusion as prescribed by their physician. Participants will be followed for up to 12 months.
There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease
NCT06965374
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease
NCT06107426
Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease
NCT04380142
PF 06412562 in Subjects With Advanced Stage Parkinson's Disease
NCT03665454
A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease
NCT06055985
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Foscarbidopa / Foslevodopa
Participants will receive foscarbidopa/ foslevodopa as prescribed by their physician according to local label
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants eligible for foscarbidopa / foslevodopa according to French label \& regulation.
* Treatment initiation decision prior to and independently from study enrolment
Exclusion Criteria
* Participants with Mini mental state examination (MMSE) score \< 24
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ABBVIE INC.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Les Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre /ID# 266843
Strasbourg, Alsace, France
Centre Hospitalier Universitaire Gabriel-Montpied /ID# 267182
Clermont-Ferrand, Auvergne-Rhône-Alpes, France
Hôpital La Timone /ID# 265932
Marseille, Bouches-du-Rhone, France
CH de Saint-Brieuc, Paimpol et Tréguier /ID# 266927
Saint-Brieuc, Brittany Region, France
Centre Hospitalier Régional Universitaire de Besançon - Hôpital Jean Minjoz /ID# 266853
Besançon, Doubs, France
CHU Brest /ID# 266405
Brest, Finistere, France
Chu de Limoges /Id# 266043
Limoges, Franche-Comte, France
Hôpitaux Civils de Colmar - Hôpital Pasteur /ID# 266932
Colmar, Grand Est, France
Centre Hospitalier Régional Universitaire de Lille - Hôpital Roger Salengro /ID# 265954
Lille, Hauts-de-France, France
Clinique Beausoleil /ID# 266920
Montpellier, Herault, France
Centre Hospitalier Universitaire de Rennes - Hôpital Pontchaillou /ID# 267665
Rennes, Ille-et-Vilaine, France
CH Bretagne Atlantique /ID# 268308
Vannes, Morbihan, France
Chu De Toulouse - Hopital Pierre Paul Ricquet /ID# 266031
Toulouse, Occitanie, France
Hopitaux Universitaires Henri Mondor - Hopital Henri Mondor /ID# 266034
Créteil, Paris, France
Centre Hospitalier d'Avignon /ID# 266369
Avignon, Provence-Alpes-Côte d'Azur Region, France
Centre Hospitalier de la Côte Basque /ID# 266846
Bayonne, Pyrenees-Atlantiques, France
les Hospices Civils de Lyon (HCL) /ID# 266404
Lyon, Rhone, France
CHU Amiens-Picardie Site Sud /ID# 266039
Amiens, Somme, France
Centre Hospitalier Intercommunal Toulon /ID# 266397
Toulon, Var, France
Centre Hospitalier Emile Durkheim - Site Plateau de la Justice /ID# 267183
Épinal, Vosges, France
Cabinet de Neurologie /ID# 268309
Versailles, Yvelines, France
Ch Bethune - Beuvry /Id# 265994
Béthune, , France
Centre hospitalier de Brive /ID# 265952
Brive-la-Gaillarde, , France
Centre Hospitalier Public du Cotentin - Hôpital Pasteur /ID# 265950
Cherbourg, , France
CH Haguenau /ID# 266029
Haguenau, , France
CHRU de NANCY /ID# 266385
Nancy, , France
Centre Hospitalier Universitaire de Nîmes - Hôpital Universitaire Carémeau /ID# 266375
Nîmes, , France
Hôpital Fondation Adolphe de Rothschild /ID# 266373
Paris, , France
CHU de Rouen /ID# 266390
Rouen, , France
CHU de Nantes - Hopital Nord Laennec /ID# 266036
Saint-Herblain, , France
Centre Hospitalier de Saint Malo /ID# 265948
St-Malo, , France
Centre Hospitalier de Valenciennes /ID# 266400
Valenciennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Site Coordinator
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P24-820
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.